Silver Book Fact

A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.

Murphy, Kevin M. and Robert H. Topel. The Value of Health and Longevity. National Bureau of Economic Research Working Paper. May-2005; 11405. http://www.nber.org/papers/W11405

Reference

Title
The Value of Health and Longevity
Publication
National Bureau of Economic Research Working Paper
Publication Date
May-2005
Authors
Murphy, Kevin M. and Robert H. Topel
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • As of July 2014, 18 anticancer drugs received FDA approval after being designated breakthrough therapies.  
  • According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development is for glioblastoma. The medicine singles out and latches onto the receptors on…  
  • An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay…  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.